(Q58910820)

2

0 references

Olla Wasfi

3

0 references

Katlyn Sheldon

4

0 references

Shawn Wettig

5

0 references

Roderick Slavcev

Journal of nanotechnology

6

0 references

publication date

2012

0 references

published in

0 references

volume

2012

0 references

page(s)

1-13

0 references

copyright license

Creative Commons Attribution 3.0 Unported

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Further Investigations on the Nature of Ultra-Microscopic Viruses and their Cultivation

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophages show promise as antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Population and evolutionary dynamics of phage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Molecular biomimetics: nanotechnology through biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Display technologies: application for the discovery of drug and gene delivery agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Cancer-specific ligands identified from screening of peptide-display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophage interactions with phagocytes and their potential significance in experimental therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacterial viruses as human vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophage-mediated nucleic acid immunisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Genetic immunisation against hepatitis B using whole bacteriophage lambda particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Uptake and processing of modified bacteriophage M13 in mice: implications for phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

The phage display technique: advantages and recent patents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Good or evil: CD26 and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Reactive oxygen species in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Effects of bacteriophages on free radical production and phagocytic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Role of free radicals in sepsis: antioxidant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Structural and thermodynamic characterization of Pal, a phage natural chimeric lysin active against pneumococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

PlyC: a multimeric bacteriophage lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

LysK, the enzyme lysing Staphylococcus aureus cells: specific kinetic features and approaches towards stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Characterization of the staphylococcal bacteriophage lysin CHAP(K).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

The bacteriophages in human- and animal body-associated microbial communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Metagenomic analysis of the human distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Getting a grip on things: how do communities of bacterial symbionts become established in our intestine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Immunological factors that affect the in vivo fate of T7 phage in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

HIV Infection and Gut Mucosal Immune Function: Updates on Pathogenesis with Implications for Management and Intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Pharmacokinetic principles of bacteriophage therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophage penetration in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Targeted drug-carrying bacteriophages as antibacterial nanomedicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Nanomedicine: current status and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacteriophage translocation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Regulation of Toll-like receptor signaling in the innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Bacterial manipulation of innate immunity to promote infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Deciphering the complexity of Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage phi X174 in asymptomatic HIV-1 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Fate of Bacteriophage Lambda in Non-immune Germ-free Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Long-circulating bacteriophage as antibacterial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

The prospect for bacteriophage therapy in Western medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

The interactions of peptides with the innate immune system studied with use of T7 phage peptide display

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Inhibitory receptors of the immune system: functions and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

The complement system in regulation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Structural insights into the central complement component C3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Abnormal antibody responses in patients with persistent generalized lymphadenopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Antibiodies of the IgG, IgM, and IgA classes in newborn and adult sera reactive with gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

Antibody responses to bacteriophage phi X-174 in human subjects exposed to the antarctic winter-over model of spaceflight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427

IgA response of BALB/c mice to orally administered Salmonella typhimurium flagellin-displaying T2 bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F247427